Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Volt Pharma Associates

    VPA supports life sciences companies, investors and academic institutes in developing new products, technologies and innovative approaches. VPA’s aim is to solve our clients’ product research, development and commercialisation challenges so they can achieve their business goals.

    This is a FREE LISTING on PMHUB

    Below are full profiles from other companies in related areas

    Genesis Research Group logo

    Genesis Research Group

    Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…

    View Profile

    Market access, Regulatory affairs, Research and development

    Company Details

    Volt Pharma Associates
    Engesserstrasse 4B, Freiburg, 79114, Germany
    +49 172 6340202
    Contact Volt Pharma Associates
    Website

     Latest Content from PMHub 

    Creating a Lifeline to the New Digital User

    White Papers and Resources | January 3, 2014 | Havas Lynx

    Today, we’re focussed on getting to know our new target: she’s online, mobile, and connected to a large network of friends, information, and marketers who help her make decisions about...

    Warehousing of HCV patients reaches new high

    White Papers and Resources | December 19, 2013 | Inizio

    A new study conducted by Research Partnership reveals that 90% of physicians treating HCV patients in the US have reported they are now “warehousing” patients (holding off treatment) in expectation...

    Brand leaders in RA will lose market share, predict rheumatologists

    White Papers and Resources | December 19, 2013 | Inizio

    Rheumatologists believe that the current market for biologic treatments in Rheumatoid Arthritis (RA) will see key changes in the next three years.

    Removing the Roadblocks to Effective Patient Treatment

    White Papers and Resources | November 22, 2013 | Inizio

    How can pharma benefit from improved patient understanding? Welcome to a new column in which Mary Assimakopoulos, Founding Director of pharma market research specialist the Research Partnership reveals findings from...

    Driving Earlier Diagnosis: A Case Study in Psoriatic Arthritis

    White Papers and Resources | November 22, 2013 | Inizio

    Following a survey of 1000 Psoriatic Arthritis patients, Mary Assimakopoulos shares some of the root causes behind a late diagnosis of this debilitating illness, and the patients’ own feelings towards...

    The Difficulties of Living with Depression Don’t End with the Illness Itself

    White Papers and Resources | November 22, 2013 | Inizio

    This month Mary Assimakopoulos examines some of the insights gathered while surveying 2,000 patients suffering with this often misunderstood mental illness.

    Patient Power: Too Much of a Good Thing?

    White Papers and Resources | November 22, 2013 | Inizio

    Mary Assimakopoulos, reveals findings from the company’s Therapy Watch market research data, investigating patient behaviour in Crohn’s Disease and discusses how pharma can benefit from improved patient understanding

    He who dares wins

    White Papers and Resources | November 15, 2013 | Lucid Group Communications Limited

    The benefits of including medical experts in your brand planning team

    Guide to Customer Experience for Pharma

    White Papers and Resources | November 5, 2013 | Blue Latitude Health

    Find out how to overcome your customer experience challenges

    Does your medical education drive change in clinical practice?

    White Papers and Resources | October 18, 2013 | Lucid Group Communications Limited

    How to advance outcomes for patients using a medical education process, by Jan Steele PhD, operations director, Lucid